Stock Research: TELA Bio

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

TELA Bio

NasdaqGM:TELA US8723811084
47
  • Value
    40
  • Growth
    71
  • Safety
    Safety
    52
  • Combined
    58
  • Sentiment
    41
  • 360° View
    360° View
    47
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

TELA Bio, Inc. is a medical technology company providing soft-tissue reconstruction solutions for hernia repair, abdominal wall reconstruction, and plastic/reconstructive surgery with products like OviTex and OviTex PRS. In the last fiscal year, the company had 209 employees, a market cap of $81 million, profits of $46 million, and revenue of $69 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 47 (better than 47% compared with alternatives), overall professional sentiment and financial characteristics for the stock TELA Bio are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for TELA Bio. The consolidated Value Rank has an attractive rank of 52, which means that the share price of TELA Bio is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 52% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 71, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 41. Professional investors are more confident in 59% other stocks. Worryingly, the company has risky financing, with a Safety rank of 40. This means 60% of comparable companies have a safer financing structure than TELA Bio. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
52 81 47 47
Growth
71 65 47 55
Safety
Safety
40 19 42 58
Sentiment
41 49 49 80
360° View
360° View
47 72 40 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
74 83 71 86
Opinions Change
50 50 50 13
Pro Holdings
n/a 22 14 67
Market Pulse
34 48 78 79
Sentiment
41 49 49 80
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
52 81 47 47
Growth
71 65 47 55
Safety Safety
40 19 42 58
Combined
58 70 34 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
36 36 36 36
Price vs. Earnings (P/E)
91 78 67 58
Price vs. Book (P/B)
25 100 37 26
Dividend Yield
1 1 1 1
Value
52 81 47 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
90 90 77 87
Profit Growth
34 71 41 41
Capital Growth
87 65 85 41
Stock Returns
25 11 23 51
Growth
71 65 47 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
16 12 6 32
Refinancing
87 63 79 75
Liquidity
31 43 52 42
Safety Safety
40 19 42 58

Similar Stocks

Discover high‑ranked alternatives to TELA Bio and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.